Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PANACEA BIOTECH vs WYETH - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    PANACEA BIOTECH WYETH PANACEA BIOTECH/
WYETH
 
P/E (TTM) x -60.9 27.7 - View Chart
P/BV x 0.9 11.3 7.8% View Chart
Dividend Yield % 0.0 10.9 -  

Financials

 PANACEA BIOTECH   WYETH
EQUITY SHARE DATA
    PANACEA BIOTECH
Mar-23
WYETH
Mar-14
PANACEA BIOTECH/
WYETH
5-Yr Chart
Click to enlarge
High Rs1911,065 18.0%   
Low Rs107553 19.4%   
Sales per share (Unadj.) Rs75.1289.5 25.9%  
Earnings per share (Unadj.) Rs-5.538.7 -14.2%  
Cash flow per share (Unadj.) Rs0.939.9 2.2%  
Dividends per share (Unadj.) Rs0145.00 0.0%  
Avg Dividend yield %017.9 0.0%  
Book value per share (Unadj.) Rs137.7118.5 116.2%  
Shares outstanding (eoy) m61.2522.72 269.6%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x2.02.8 71.1%   
Avg P/E ratio x-27.120.9 -129.6%  
P/CF ratio (eoy) x170.020.3 838.4%  
Price / Book Value ratio x1.16.8 15.9%  
Dividend payout %0374.7 -0.0%   
Avg Mkt Cap Rs m9,14218,381 49.7%   
No. of employees `000NANA-   
Total wages/salary Rs m1,265359 352.8%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m4,5996,577 69.9%  
Other income Rs m517347 148.7%   
Total revenues Rs m5,1166,925 73.9%   
Gross profit Rs m471,023 4.6%  
Depreciation Rs m39127 1,428.9%   
Interest Rs m444 1,010.7%   
Profit before tax Rs m1281,339 9.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m466460 101.3%   
Profit after tax Rs m-337879 -38.4%  
Gross profit margin %1.015.6 6.6%  
Effective tax rate %363.534.3 1,058.9%   
Net profit margin %-7.313.4 -54.9%  
BALANCE SHEET DATA
Current assets Rs m5,6233,964 141.9%   
Current liabilities Rs m3,2972,081 158.4%   
Net working cap to sales %50.628.6 176.6%  
Current ratio x1.71.9 89.5%  
Inventory Days Days5935 167.3%  
Debtors Days Days48278 17.2%  
Net fixed assets Rs m7,028878 800.6%   
Share capital Rs m61227 27.0%   
"Free" reserves Rs m8,3752,466 339.7%   
Net worth Rs m8,4362,693 313.3%   
Long term debt Rs m20225 805.9%   
Total assets Rs m12,7124,842 262.5%  
Interest coverage x3.9306.0 1.3%   
Debt to equity ratio x00 257.3%  
Sales to assets ratio x0.41.4 26.6%   
Return on assets %-2.318.2 -12.6%  
Return on equity %-4.032.6 -12.3%  
Return on capital %2.049.4 4.0%  
Exports to sales %43.30.1 37,515.1%   
Imports to sales %24.434.7 70.4%   
Exports (fob) Rs m1,9928 26,248.4%   
Imports (cif) Rs m1,1242,281 49.3%   
Fx inflow Rs m1,9928 26,179.4%   
Fx outflow Rs m1,1912,298 51.8%   
Net fx Rs m801-2,291 -35.0%   
CASH FLOW
From Operations Rs m-4,2251,188 -355.5%  
From Investments Rs m4,303287 1,500.1%  
From Financial Activity Rs m-184-4,296 4.3%  
Net Cashflow Rs m-105-2,821 3.7%  

Share Holding

Indian Promoters % 73.6 0.0 -  
Foreign collaborators % 0.0 51.1 -  
Indian inst/Mut Fund % 1.0 18.4 5.2%  
FIIs % 0.3 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 26.4 48.9 54.0%  
Shareholders   47,091 25,706 183.2%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare PANACEA BIOTECH With:   SUN PHARMA    DIVIS LABORATORIES    CIPLA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Panacea Biotech vs WYETH

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Panacea Biotech vs WYETH Share Price Performance

Period Panacea Biotech WYETH S&P BSE HEALTHCARE
1-Day -1.74% -2.27% 1.18%
1-Month -20.01% 18.58% -0.75%
1-Year 11.75% 69.59% 61.82%
3-Year CAGR -12.26% 15.36% 18.16%
5-Year CAGR -9.98% 8.95% 19.79%

* Compound Annual Growth Rate

Here are more details on the Panacea Biotech share price and the WYETH share price.

Moving on to shareholding structures...

The promoters of Panacea Biotech hold a 73.6% stake in the company. In case of WYETH the stake stands at 51.1%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Panacea Biotech and the shareholding pattern of WYETH.

Finally, a word on dividends...

In the most recent financial year, Panacea Biotech paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of -0.0%.

WYETH paid Rs 145.0, and its dividend payout ratio stood at 374.7%.

You may visit here to review the dividend history of Panacea Biotech, and the dividend history of WYETH.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.